Methods: This was a single-center study using retrospective chart review and an institutional database for follow-up information. Data analyzed included number and year of primary AVSD and redo-LAVV operation, presence of trisomy 21, morphology of AVSD, mortality, and reoperation. Univariate analysis included repair and replacement rates and early and long-term survival.
| INTRODUCTION
Results of atrio-ventricular septal defect (AVSD) repair in the current era have proved to be excellent in the short and long term [1] [2] [3] but postoperative left atrio-ventricular valve (LAVV) regurgitation can still be a significant problem and is estimated to occur in up to 18% of patients. [4] [5] [6] [7] [8] [9] Risk factors for LAVV regurgitation such as presence of dysplastic, double orifice, or parachute LAVV have been identified, 6, [10] [11] [12] [13] [14] [15] as have strategies to reduce the risk, including early primary repair, routine cleft closure, and annular stabilization. 2, [10] [11] [12] [16] [17] [18] [19] Nonetheless, LAVV regurgitation remains the main reason for reoperation after AVSD repair. 4, [7] [8] [9] [10] [11] [12] [13] At the time of redo-surgery, LAVV repair techniques are normally considered preferable to replacement due preservation of the subvalvar apparatus, improved long-term left ventricular function, and potential for growth. 10, 13, 14, 17 Moreover, the need for permanent anticoagulation and higher incidence of pacemaker (PM) implant associated with mechanical LAVV replacement are known to contribute to poor outcomes. 20, 21 The objective of our study was to review our experience with preservation of the LAVV at the time of redo surgery and how this has changed over time.
| METHODS
We studied all consecutive patients reoperated for LAVV failure 
| Indication and techniques for LAVV reoperation
Indication for redo-LAVV surgery was based on echocardiographic imaging, symptoms, and, occasionally, cardiac catheter findings. In the last 4 years a routine magnetic resonance imaging scan was added to assess myocardial and LAVV function and to plan sternal re-entry. This has been shown to decrease injury to the myocardium and great vessels in redo valve procedures. 22 All patients had severe LAVV regurgitation.
Redo-operation was performed through a redo-median sternotomy and on cardio-pulmonary bypass (CPB). No patient required peripheral cannulation for CPB. Access to the LAVV was gained through the inter-atrial groove or via a right atriotomy through the repaired primum atrial septal defect (ASD). Decision-making regarding LAVV repair versus replacement was guided by intraoperative echocardiography and inspection of the LAVV. Replacement was performed in cases of a severely dysplastic valve or as a bailout after a failed attempt at repair. If there were other hemodynamic important lesions then these were also addressed at the time of the operation.
| Statistics
Categorical variables are expressed as numbers and percentages.
Continuous variables, which had a skewed distribution, were described with median and interquartile range. Association between parameters was tested using univariate step analysis with the Pearson's chi-square or 
| Early outcome
Twenty-eight patients (78%) underwent LAVVRepair and eight (22%)
LAVVR. There was no significant difference between the two groups with regard to their preoperative risk profile (Table 1) .
Valve repair techniques included cleft closure, annuloplasty, leaflet patching, artificial chord implantation, and splitting of the subvalvar apparatus, alone or as combined procedures ( Table 2 There was a tendency for a higher need for permanent pacemaker in patients who received LAVVR (3/8 patients-37% vs 2/28 patients-7%), but this did not reach statistical significance.
Three patients (8%) had moderate residual LAVV regurgitation after LAVVRepair on postoperative echocardiography. One patient has been maintained on medical treatment, and two required LAVVR within 1 week of repair. One of these patients developed prosthetic valve thrombosis 3 months later and was treated with local fibrinolysis and thrombus aspiration. Unfortunately, this treatment failed and the patient died shortly after from heart failure. The other patient required re-exploration for bleeding after LAVVR as well as a permanent pacemaker implant for complete heart block (CHB).
One patient underwent LAVVR 6 days following cAVSD repair and subsequently was found to have a hemodynamic significant VSD 2 months later for which he underwent pulmonary artery banding. Early postrepair LAVV failure 5 (14) 4 (14) 1 (12) 1 Other associated cardiac anomalies (%) 3.3 | Long-term outcome Two out of seven LAVVR patients were in AF, compared to only one patient after LAVVRepair. There was an overall incidence of postoperative CHB of 19%, which was most pronounced in the LAVVR early postop period, with three out of eight patients requiring a PM.
Except for the earlier described patient with valve thrombosis, there were no reported anticoagulation-related bleeding or thrombotic events nor para-valvar leaks.
Eight patients (22%) underwent further cardiac surgery after their redo-LAVV procedure. In the LAVVRepair group five patients (18%) underwent either a LAVVR (four patients, including the previously described valve thrombosis) or LVOTO resection (one patient). In the LAVVR group, three patients (37%) underwent further prosthetic LAVV replacement either isolated or associated with other procedures (Table 3) .
Estimated survival at 60 months was 96% for LAVVRepair and 87% for LAVVR, respectively ( Figure 1 ). Estimated freedom from reoperation at 60 months was 85% after LAVVR and 86% after LAVVRepair, respectively (Figure 2 ).
| Subgroup analysis
In the early part of the study (2004) (2005) (2006) (2007) (2008) (2009) (2010) , the LAVV could be preserved in 54% of patients, compared to 91% in the later part of the study (P < 0.01) ( Table 4 ). The absolute number of redo-operations for Early reoperation (%) 3 (8) 2 (7) The ability to preserve the LAVV at redo-repair did not appear to be different between patients with cAVSD, pAVSD, or trisomy 21 (Table 4 ).
| DISCUSSION
Valve repair in congenital surgery is now being increasingly performed in the aortic, mitral, and tricuspid positions.
23-26
The present study shows that in the current era it is increasingly possible to achieve a successful redo-LAVV repair with good early and long-term results.
This is in keeping with reports by others. [10] [11] [12] [13] [14] 17, 19 The significant rise in the repair rate from 54% to 91% is In addition, the use of a posterior annuloplasty band fashioned from trigone to trigone helps correct the dilated annulus, thereby reducing the tension on the suture line as well as improving the area of coaptation between the leaflets. 27 Fully flexible bands or pericardial strips, rather than stiff mitral bands, should be used, since in AVSD the aorta is unwedged from the fibrous skeleton of the heart and the LAVV annulus does not conform to the shape of the normal mitral valve. Pontailler et al suggested trimming some of the secondary chords to relieve tethering of the LAVV and tension on the apposed leaflets as well as to create more space in the LVOT. 17 We agree that this could be useful in selected cases. The time to reoperation was longer in the second part of the study.
This may reflect that overall follow-up after AVSD repair is now longer, as well as an increased rate of referral of patients that were previously not judged candidates for repair.
In our study, mortality was low and there was no statistical difference in late survival or freedom from reoperation between LAVVR and LAVVRepair. Similar results have been reported by other groups.
11-12
The patient who died in the LAVVRepair group did eventually die from complications related to a thrombosis of a mechanical valve prosthesis implanted following a failed LAVVRepair. Moreover, a higher proportion of patients in the LAVVR group underwent re-operation compared to the LAVVRep air group (42% vs 11%). Similar findings related to mechanical mitral prostheses in children have been reported 10, 13, 14, 17 and are particularly relevant in young children who have a lifetime exposure to the risks of the prosthesis, including the need for repeat valve replacement due to somatic outgrowth of the prosthesis.
20,21
The presence of trisomy 21 did not appear to affect the proportion of repairs or the outcome of the operation. Many other reports have stated that trisomy 21 is not a risk factor for early and long-term survival 6, 28, 29 and may even be a protective factor for reoperation due to less prevalence of LAVV anomalies. [28] [29] [30] Some groups found a lower freedom from reoperation for patients with cAVSD compared to pAVSD. 11 In our study, the morphology of 
| LIMITATIONS
Limitations of this study include its retrospective nature, the relatively small number of patients and events, and the presence of an era effect.
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